Close

Leerink Swann Raises Allscripts (MDRX) to Outperform Following PHM Survey and Analysis

November 15, 2013 7:38 AM EST Send to a Friend
Leerink Swann upgraded Allscripts (NASDAQ: MDRX) from Market Perform to Outperform with a price target of $18.00 (from $16.00). Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login